Cancer cases are on the rise worldwide, and India is at the epicentre of this growing crisis. In recent estimates, India has more than 1.5 million cancer cases diagnosed every year, expected to rise by 12% by 2025. The demand …
Small-medium enterprises in the pharmaceutics sectors play a major role in innovation within the industry. However, the financial constraints are generally so limiting that most of these organisations have not really been able to scale up their production and license …
India’s oncology pharma market, one of the most significant in global anti-cancer treatment, is thought to be suffering due to mighty supply chain challenges. Approximately 50 percent of all oncology drugs in India are brought in from other countries, with …
Cancer is one of the leading health concerns worldwide–yet the groundbreaking research and innovative drug development have somehow transformed patient outcomes. In global oncology medicine manufacturers, India is now recognised as one of the top leaders. Indian oncology has even …
India has emerged as a powerhouse in the global oncology pharmaceutical market. With affordable drug manufacturing, a skilled workforce, and cutting-edge R&D facilities, the country is shaping the future of cancer treatment worldwide. A report states that India’s oncology market …
Are you aware of how India contributes to a world victory in the war against cancer? Typically, Indian oncology medicine manufacturing strengthens the local healthcare system while also adding efficiency to cancer treatment worldwide. Oncology drug manufacturers in India are …
Oncology CDMOs are changing the drug industry by making the process of making cancer drugs more accurate, professional, and scalable. One of the biggest problems in modern medicine is cancer. To make good oncology drugs, we need both new scientific ...
Introduction Selecting a pharmaceutical company that manufactures top-notch oncology medications is essential, particularly as the need for cancer treatment grows. In India, one in nine people will receive a cancer diagnosis at some point in their lives, and every case …
Is third-party manufacturing the future of pharma? Driven by a push toward cost-saving, specialization, and strict regulatory demands, the pharmaceutical industry is shifting gears fast. Global contract manufacturing is projected to grow from $344.92 billion in 2023 to $604.11 billion …
How does one turn a promising gene therapy from a concept in the lab into a life-altering medicine for millions? All drugs face complex journeys from the laboratory to the market, but cell and gene therapies require specific differentiated expertise ...